T-ALL is characterized by dysregulation of critical signaling pathways, including NOTCH1, PI3K/AKT/mTOR, and JAK/STAT, which play pivotal roles in T-cell development and leukemogenesis. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.